N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide

C105H102F12N16O11 — CID 159346000

About N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide

N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide (PubChem CID 159346000) has the molecular formula C105H102F12N16O11 and a molecular weight of 1992.05 g/mol. Its IUPAC name is N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide.

Molecular Properties

• Compound Name: N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide
• PubChem CID: 159346000
• Molecular Formula: C105H102F12N16O11
• Molecular Weight: 1992.05 g/mol
• Exact Mass: 1990.77
• IUPAC Name: N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide
• SMILES: CC(=O)NC(Cc1ccc(C)cc1)c1nnc(-c2ccc(F)cc2)o1.CC(=O)NC(Cc1ccc(C)cc1)c1nnc(-c2ccncc2)o1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(F)c3)o2)cc1.CCc1cccc(CC(NC(=O)C2CCCCC2)c2nnc(-c3cccc(OC(F)(F)F)c3)o2)c1
• InChI: InChI=1S/C26H28F3N3O3.C22H19F6N3O2.C20H19F2N3O2.C19H18FN3O2.C18H18N4O2/c1-2-17-8-6-9-18(14-17)15-22(30-23(33)19-10-4-3-5-11-19)25-32-31-24(34-25)20-12-7-13-21(16-20)35-26(27,28)29;1-3-13-4-6-14(7-5-13)8-18(29-12(2)32)20-31-30-19(33-20)15-9-16(21(23,24)25)11-17(10-15)22(26,27)28;1-3-13-4-6-14(7-5-13)10-18(23-12(2)26)20-25-24-19(27-20)15-8-9-16(21)17(22)11-15;1-12-3-5-14(6-4-12)11-17(21-13(2)24)19-23-22-18(25-19)15-7-9-16(20)10-8-15;1-12-3-5-14(6-4-12)11-16(20-13(2)23)18-22-21-17(24-18)15-7-9-19-10-8-15/h6-9,12-14,16,19,22H,2-5,10-11,15H2,1H3,(H,30,33);4-7,9-11,18H,3,8H2,1-2H3,(H,29,32);4-9,11,18H,3,10H2,1-2H3,(H,23,26);3-10,17H,11H2,1-2H3,(H,21,24);3-10,16H,11H2,1-2H3,(H,20,23)
• InChIKey: LGSRPDZUOFFKCQ-UHFFFAOYSA-N
• XLogP: 22.40
• TPSA: 362.22 Ų
• H-Bond Donors: 5
• H-Bond Acceptors: 22
• Rotatable Bonds: 30
• Heavy Atoms: 144
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	1992.05
LogP ≤ 5	22.40
H-Bond Donors ≤ 5	5
H-Bond Acceptors ≤ 10	22

Frequently Asked Questions

What is the IUPAC name of N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide?

The IUPAC name of N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide (CID 159346000) is N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide.

What is the SMILES notation for N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide?

The canonical SMILES for N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide is CC(=O)NC(Cc1ccc(C)cc1)c1nnc(-c2ccc(F)cc2)o1.CC(=O)NC(Cc1ccc(C)cc1)c1nnc(-c2ccncc2)o1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)o2)cc1.CCc1ccc(CC(NC(C)=O)c2nnc(-c3ccc(F)c(F)c3)o2)cc1.CCc1cccc(CC(NC(=O)C2CCCCC2)c2nnc(-c3cccc(OC(F)(F)F)c3)o2)c1.

What is the InChIKey of N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide?

The InChIKey is LGSRPDZUOFFKCQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H28F3N3O3.C22H19F6N3O2.C20H19F2N3O2.C19H18FN3O2.C18H18N4O2/c1-2-17-8-6-9-18(14-17)15-22(30-23(33)19-10-4-3-5-11-19)25-32-31-24(34-25)20-12-7-13-21(16-20)35-26(27,28)29;1-3-13-4-6-14(7-5-13)8-18(29-12(2)32)20-31-30-19(33-20)15-9-16(21(23,24)25)11-17(10-15)22(26,27)28;1-3-13-4-6-14(7-5-13)10-18(23-12(2)26)20-25-24-19(27-20)15-8-9-16(21)17(22)11-15;1-12-3-5-14(6-4-12)11-17(21-13(2)24)19-23-22-18(25-19)15-7-9-16(20)10-8-15;1-12-3-5-14(6-4-12)11-16(20-13(2)23)18-22-21-17(24-18)15-7-9-19-10-8-15/h6-9,12-14,16,19,22H,2-5,10-11,15H2,1H3,(H,30,33);4-7,9-11,18H,3,8H2,1-2H3,(H,29,32);4-9,11,18H,3,10H2,1-2H3,(H,23,26);3-10,17H,11H2,1-2H3,(H,21,24);3-10,16H,11H2,1-2H3,(H,20,23).

What are the key properties of N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide?

N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide has a molecular weight of 1992.05 g/mol, XLogP of 22.40, 30 rotatable bonds, 5 hydrogen bond donors, and 22 hydrogen bond acceptors.

Where does this data come from?

All data for N-[1-[5-[3,5-bis(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[1-[5-(3,4-difluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-ethylphenyl)ethyl]acetamide;N-[2-(3-ethylphenyl)-1-[5-[3-(trifluoromethoxy)phenyl]-1,3,4-oxadiazol-2-yl]ethyl]cyclohexanecarboxamide;N-[1-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-2-(4-methylphenyl)ethyl]acetamide;N-[2-(4-methylphenyl)-1-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)ethyl]acetamide is sourced from PubChem (CID 159346000), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).